Ripretinib + Cyp3a Inducers Interaction
Majorinteraction on record
Description
Coadministration decreases ripretinib and active metabolite exposure, which may decrease anti-tumor activity. Avoid concomitant use.
Mechanism
CYP3A induction
Source: NLP:ripretinib